GIBSON ROBERT J enters SCOPUS BIOPHARMA INC. with 412.05K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/15/2020ACC: 0001104659-20-135877
DirectorOfficer· Vice Chairman
Since Dec 2020
412.05K
Baseline shares
0% direct
2K
Direct ownership
1 position
776.17K
Derivative underlying
2 instruments
3
Security positions
410.05K indirect
Non-Derivative Holdings3
Common Stock, par value $0.001
DirectShares owned2K
Common Stock, par value $0.001
IndirectShares owned210.05K
Common Stock, par value $0.001
IndirectShares owned200K
Total
2K direct·410.05K indirect412.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 | 2K | Direct |
| Common Stock, par value $0.001 | 210.05K | Indirect |
| Common Stock, par value $0.001 | 200K | Indirect |
| Total | 412.05K | 2K direct·410.05K indirect |
Derivative Holdings2
W Warrant
IndirectUnderlying security
B Unit
Underlying shares
6.67K
Shares owned
N/A
Exercise price
4.00
Expiration
—
Exercise window
—
W Warrant
IndirectUnderlying security
B Unit
Underlying shares
769.50K
Shares owned
N/A
Exercise price
4.00
Expiration
—
Exercise window
—
Total
Underlying
776.17K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| W Warrant Indirect | B Unit | 4.00 | — | — | 6.67K | N/A |
| W Warrant Indirect | B Unit | 4.00 | — | — | 769.50K | N/A |
| Total | 776.17K | 0.00 | ||||